Top Stories
-
An engineer and a physician are working together to pioneer a new approach using focused ultrasound to treat dozens of brain diseases.
Topic
-
A new study forecasts a substantial rise in uterine cancer cases and deaths over the next three decades, with a disproportionate impact on Black women.
Topic
-
Diagnosed with stage 3 bladder cancer, Jeffrey Pulver underwent chemo, surgery, and a neobladder at Columbia—just in time to walk his daughter down the aisle, cancer-free, on their family farm.
-
Two teams at the Vagelos College of Physicians and Surgeons are working to train patients’ immune cells to seek and destroy rogue cells that cause cancer and autoimmune diseases.
Topic
Latest News
- October 9, 2017
Riders, sponsors, volunteers, and friends joined forces for Velocity, Columbia's Ride to End Cancer, in support of the Herbert Irving Comprehensive Cancer Center.
Topic
- September 7, 2017
Cancer immunotherapy drugs only work for a minority of patients, but a generic drug now used to increase blood flow may be able to improve those odds, a study by Columbia University Medical Center researchers suggests.
Topic
- August 30, 2017
Immunotherapy expert Pawel Muranski speaks about the new CAR-T therapy for leukemia and his work to bring T cell therapies to patients with a wide range of cancers.
Topic
- August 30, 2017
Prakash Satwani, MD, leads NYP/CUIMC's program in CAR-T therapy, a new treatment that uses a patient's own T cells to attack cancer.
Topic
- July 11, 2017
Inna Kleyman, MD, shares why she joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Topic
- July 11, 2017
Alexander Small, MD, shares why he joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUMC.
Topic
- July 11, 2017
Ilene Anesini shares why she joined Velocity, a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUIMC.
Topic
- July 10, 2017
Velocity is a new cycling event that benefits the Herbert Irving Comprehensive Cancer Center at CUIMC. Columbia riders share why they joined the cause.
Topic
- May 4, 2017
Researchers discovered a mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy.
Topic
- April 6, 2017
Columbia University scientists study tumor revertants as possible new approach to cancer therapy.
Topic
